Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence
Open Access
- 1 March 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (3), 643-652
- https://doi.org/10.1111/j.1476-5381.1992.tb09033.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Estimation of agonist affinity and efficacy by direct, operational model-fittingJournal of Pharmacological Methods, 1990
- Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glandsBiochemical and Biophysical Research Communications, 1989
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- MUSCARINIC RECEPTOR SUBTYPES: A CRITIQUE OF THE CURRENT CLASSIFICATION AND A PROPOSAL FOR A WORKING NOMENCLATUREJournal of Autonomic Pharmacology, 1986
- The affinity of some selective muscarinic receptor antagonists for the muscarinic receptor mediating endothelial-dependent relaxation of the rabbit and rat thoracic aortaJournal of Pharmacy and Pharmacology, 1986
- Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assayInflammation Research, 1985
- Operational models of pharmacological agonismProceedings of the Royal Society of London. B. Biological Sciences, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Analysis of the interaction between histamine H2-receptor antagonists and pentagastrinInflammation Research, 1978